111 (NASDAQ:YI) Trading Down 0.5%

Shares of 111, Inc. (NASDAQ:YIGet Rating) traded down 0.5% on Thursday . The company traded as low as $1.93 and last traded at $2.06. 185,995 shares were traded during trading, a decline of 69% from the average session volume of 592,745 shares. The stock had previously closed at $2.07.

The firm has a market cap of $173.62 million, a PE ratio of -1.75 and a beta of 0.91. The stock has a fifty day simple moving average of $1.91 and a two-hundred day simple moving average of $2.53.

A number of hedge funds have recently bought and sold shares of the business. Renaissance Technologies LLC boosted its position in shares of 111 by 61.9% during the 1st quarter. Renaissance Technologies LLC now owns 32,947 shares of the company’s stock valued at $88,000 after acquiring an additional 12,600 shares during the last quarter. Jane Street Group LLC boosted its position in shares of 111 by 221.1% during the 1st quarter. Jane Street Group LLC now owns 39,917 shares of the company’s stock valued at $106,000 after acquiring an additional 27,484 shares during the last quarter. Invesco Ltd. boosted its position in shares of 111 by 59.0% during the 1st quarter. Invesco Ltd. now owns 52,423 shares of the company’s stock valued at $139,000 after acquiring an additional 19,454 shares during the last quarter. Finally, State Street Corp boosted its position in shares of 111 by 17.9% during the 1st quarter. State Street Corp now owns 147,142 shares of the company’s stock valued at $391,000 after acquiring an additional 22,329 shares during the last quarter. 4.67% of the stock is owned by institutional investors and hedge funds.

About 111 (NASDAQ:YI)

111, Inc operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers.

Recommended Stories

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.